Loading...
Indian Pharmaceutical Exporter · #7 for Tetracycline · $385.4K export value · DGFT Verified
Laborate Pharmaceuticals India Ltd is the #7 Indian exporter of Tetracycline with $385.4K in export value and 17 verified shipments. Laborate Pharmaceuticals India Ltd holds a 2.3% market share in Tetracycline exports across 7 countries.
| $17.8K |
| 1 |
| 4.4% |
| LIBERIA | $11.5K | 1 | 2.8% |
| MAURITANIA | $9.4K | 4 | 2.3% |
Laborate Pharmaceuticals India Ltd exports Tetracycline to 7 countries. The largest destination is NIGERIA accounting for 43.4% of Laborate Pharmaceuticals India Ltd's Tetracycline shipments, followed by TAJIKISTAN (25.3%) and KENYA (12.3%). These destinations reflect Laborate Pharmaceuticals India Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF EMBASSY PHARMACEUTI | NIGERIA | $94.9K | 2 |
| EMBASSY PHARMACEUTICAL & CHEMICALS | NIGERIA | $69.5K | 3 |
| TO THE ORDER OF EXIM BANK UGANDA LI | KENYA | $50.0K | 1 |
| M/S "QUBOD PHARMA" REPUBLIC OF TAJI | TAJIKISTAN | $50.0K | 1 |
| STE PRINCE PHARMA SARL | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $38.7K | 1 |
| MS "QUBOD PHRAMA" REPUBLIC OF TAJI | TAJIKISTAN | $36.7K | 3 |
| NANDRLON COMPANY FOR PHARMACEUTICAL | TURKEY | $17.8K | 1 |
| TO THE ORDER OF | TAJIKISTAN | $14.4K | 1 |
| EMBASSY PHARMACEUTICAL AND CHEMICAL | NIGERIA | $12.3K | 1 |
| WINNER'S PHARMACEUTICALS | LIBERIA | $11.5K | 1 |
Laborate Pharmaceuticals India Ltd supplies Tetracycline to 12 buyers globally. The largest buyer is TO THE ORDER OF EMBASSY PHARMACEUTI (NIGERIA), followed by EMBASSY PHARMACEUTICAL & CHEMICALS (NIGERIA) and TO THE ORDER OF EXIM BANK UGANDA LI (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $9.7M worth of Tetracycline through 2,829 shipments from 263 suppliers to 128 countries, serving 660 buyers globally. Laborate Pharmaceuticals India Ltd contributes $385.4K to this total, accounting for 2.3% of India's Tetracycline exports. Laborate Pharmaceuticals India Ltd ships Tetracycline to 7 countries through 12 buyers.
Laborate Pharmaceuticals India Ltd's average Tetracycline shipment value is $22.7K per consignment, based on 17 shipments totaling $385.4K. The largest destination is NIGERIA (43.4% of Laborate Pharmaceuticals India Ltd's Tetracycline exports).
Laborate Pharmaceuticals India Ltd ranks #7 among 263 Indian Tetracycline exporters with a 2.3% market share. The top 3 exporters are GALENTIC PHARMA INDIA PVT LTD ($2.3M), PRASHI PHARMA PRIVATE LIMITED ($1.5M), COHANCE LIFESCIENCES LIMITED ($1.5M). Laborate Pharmaceuticals India Ltd processed 17 shipments to 7 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| 1-298 RO-TETRACYCLINE CAPSULE (Tetracycline HCI BP 250mg) BatchNos:OB02 MFG.07/24 EXP.06/27(100x10x10)(QTY: 29710 BOX 10 | $50.0K | 1 |
| PHARMACEUTICAL MEDICINE- TETRACYCLINE OINTMENT 3g (Tetracycline Hydrochloride 1%w/w) B.NO: TL38 To TL50 MFG. 12/24 EXP. | $50.0K | 1 |
| 1-1005 NIPHAMSHIN CAPSULE(Oxytetracycline Hydrochloride BP 250mg)(QTY: 50210 BOX10x1x12) BatchNos:NIPUC-009 To NIPUC-01 | $49.1K | 1 |
| 1-1002 NIPHAMSHIN CAPSULE(Oxytetracycline Hydrochloride BP 250mg)(QTY:50075 BOX10x1x12) BatchNos:NIPUC-001 To NIPUC-006 | $46.6K | 1 |
| 1 1002 NIPHAMSHIN CAPSULE Oxytetracycline Hydrochloride BP 250mg QTY 50100 BOX10x1x12 BatchNos NIPUC 015 To NIPUC 02 | $45.8K | 1 |
| 1-212 TETRACYCLINE CAPSULE (Tetracycline | $38.7K | 1 |
| TETRACYCLINE EYE OINTMENT 3GM (TETRACYCLINE HYDROCHLORIDE USP 10MG) BATCHNOS:TL01 TO TL12 MFG. 12/23 EXP. 05/26 (40X50)NOS | $36.7K | 3 |
| 698-781 TETRACYCLINE EYE OINTMENT 3gm(Te | $17.8K | 1 |
| PHARMACEUTICAL MEDICINE TETRACYCLINE TABLETB NO 25TCT01 To 25TCT03 MFG 02 25 EXP 01 28 Tetracycline BP 100mg 100x1 | $14.4K | 1 |
| 1-334 NIPHAMSHIN CAPSULE (Oxytetracycline Hydrochloride BP 250mg) (QTY: 16700 BOX 10x1x12) BatchNos:NIPUC-007 & NIPUC-00 | $13.6K | 1 |
Laborate Pharmaceuticals India Ltd exports 16 distinct Tetracycline formulations including tablets, capsules, syrups, and combination drugs. The top formulation is 1-298 RO-TETRACYCLINE CAPSULE (Tetracycline HCI BP 250mg) Ba with 1 shipments worth $50.0K.
What Laborate Pharmaceuticals India Ltd must comply with to export Tetracycline to its top destination countries
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | VIDACARE MEDICA PRIVATE LIMITED | $558.4K | 18 | 3 | $31.0K |
| 6 | BDH INDUSTRIES LIMITED | $455.6K | 34 | 6 | $13.4K |
| 7 | LABORATE PHARMACEUTICALS INDIA LTD ★ | $385.4K | 17 | 7 | $22.7K |
| 8 | ANTILA LIFESCIENCES PRIVATE LIMITED | $373.2K | 11 | 1 | $33.9K |
| 9 | BRASSICA PHARMA PRIVATE LIMITED | $350.0K | 7 | 3 | $50.0K |
Laborate Pharmaceuticals India Ltd ranks #7 among 263 Indian Tetracycline exporters. Average shipment value of $22.7K compared to the market average of $36.8K. The closest competitors by value are VIDACARE MEDICA PRIVATE LIMITED and BDH INDUSTRIES LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 438 | 15.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 393 | 13.9% |
| SAHAR AIR | 355 | 12.5% |
| DELHI AIR | 253 | 8.9% |
| NHAVA SHEVA SEA (INNSA1) | 224 | 7.9% |
| JNPT | 130 | 4.6% |
| Bombay Air | 121 | 4.3% |
| JNPT/ NHAVA SHEVA SEA | 114 | 4.0% |
Latest developments and market context
Detailed market intelligence for Tetracycline — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 128+ countries, 660+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Laborate Pharmaceuticals India Ltd's Tetracycline exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Laborate Pharmaceuticals India Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Laborate Pharmaceuticals India Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tetracycline. For current shipment-level data, contact TransData Nexus.